▼ 1.06%
prev close
With roughly one-third of the global branded diabetes treatment market, Novo Nordisk is the leading provider of diabetes care products in the world. Based in Denmark, the company manufactures and markets a variety of human and modern insulins, injectable diabetes treatments such as GLP-1 therapy, oral antidiabetic agents, and obesity treatments. Novo also has a biopharmaceutical segment (contributing less than 10% of revenue) that specializes in protein therapies for hemophilia and other disorders.
Congressional Trades
10
All tracked trades
Members Trading
4
Unique members
Net Activity
+2
6 buys · 4 sells
Members Who Traded This Stock
10 trade events
| Date | Member | Stock | Type | Amount | Filed | Signal |
|---|---|---|---|---|---|---|
| 2025-10-31 | NVONovo Nordisk A/S Common Stock | Sell | $1,001 - $15,000 | 132d ago | — | |
| 2025-10-30 | NVONovo Nordisk A/S Common Stock | Sell | $1,001 - $15,000 | 132d ago | — | |
| 2025-09-11 | NVONovo Nordisk A/S Common Stock | Buy | $1,001 - $15,000 | 162d ago | — | |
| 2025-08-04 | NVONovo Nordisk A/S Common Stock | Buy | $1,001 - $15,000 | 231d ago | — | |
| 2025-08-04 | NVONovo Nordisk A/S Common Stock | Sell | $1,001 - $15,000 | 202d ago | — | |
| 2025-08-04 | NVONovo Nordisk A/S Common Stock | Buy | $15,001 - $50,000 | 231d ago | — | |
| 2025-06-09 | NVONovo Nordisk A/S Common Stock | Buy | $1,001 - $15,000 | 232d ago | — | |
| 2025-03-27 | NVONovo Nordisk A/S Common Stock | Buy | $15,001 - $50,000 | 356d ago | — | |
| 2024-10-29 | NVONovo Nordisk A/S Common Stock | Buy | $1,001 - $15,000 | 202d ago | — | |
| 2023-07-12 | NVONovo Nordisk A/S Common Stock | Sell | $100,001 - | 963d ago | — |
2025-10-31
Lisa McClain
NVO
Amount
$1,001 - $15,000
Filed
132d ago
2025-10-30
Lisa McClain
NVO
Amount
$1,001 - $15,000
Filed
132d ago
2025-09-11
Lisa McClain
NVO
Amount
$1,001 - $15,000
Filed
162d ago
2025-08-04
Scott Scott Franklin
NVO
Amount
$1,001 - $15,000
Filed
231d ago
2025-08-04
Lisa McClain
NVO
Amount
$1,001 - $15,000
Filed
202d ago
2025-08-04
Scott Scott Franklin
NVO
Amount
$15,001 - $50,000
Filed
231d ago
2025-06-09
Lisa McClain
NVO
Amount
$1,001 - $15,000
Filed
232d ago
2025-03-27
Scott Scott Franklin
NVO
Amount
$15,001 - $50,000
Filed
356d ago
2024-10-29
Valerie Hoyle
NVO
Amount
$1,001 - $15,000
Filed
202d ago
2023-07-12
Daniel Goldman
NVO
Amount
$100,001 -
Filed
963d ago
Recent News
Powered by Polygon.io
Why Eli Lilly Stock Trounced the Market Today
Slash Your Wegovy Costs: Novo Nordisk Reveals First-Ever Subscription Plan
Heart Risks Go Beyond the Heart: Don’t Forget to Check Blood Sugar and Kidney Health
Prediction: Buying Pfizer Stock Today Could Set You Up for Life
1 Reason This Biotech Stock Could Triple Before Year-End
Trade Timeline
Congressional activity, newest first
Lisa McClain
2025-10-31 · Sale
$1,001 - $15,000
Lisa McClain
2025-10-30 · Sale
$1,001 - $15,000
Lisa McClain
2025-09-11 · Purchase
$1,001 - $15,000
Scott Scott Franklin
2025-08-04 · Purchase
$1,001 - $15,000
Lisa McClain
2025-08-04 · Sale
$1,001 - $15,000
Scott Scott Franklin
2025-08-04 · Purchase
$15,001 - $50,000
Lisa McClain
2025-06-09 · Purchase
$1,001 - $15,000
Scott Scott Franklin
2025-03-27 · Purchase
$15,001 - $50,000
Valerie Hoyle
2024-10-29 · Purchase
$1,001 - $15,000
Daniel Goldman
2023-07-12 · Sale
$100,001 -